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Abstract
Introduction—Depending upon influenza vaccination history, children aged 6 months-8 years 
need one or two doses of influenza vaccine to be considered fully vaccinated. The objectives of 
this study were to quantify the percentage of children aged 6 months-8 years who were fully 
vaccinated against influenza based on parental report, overall, by state, and by sociodemographic 
characteristics, and to examine sociodemographic characteristics associated with being fully 
vaccinated.
Methods—Data from the National Immunization Survey-Flu for the 2012-2013 and 2013-2014 
influenza seasons were analyzed in 2015 using the Kaplan-Meier method to produce vaccination 
coverage estimates. Wald chi-square tests were used to test for bivariate associations, and Cox 
proportional hazards models were used to test for demographic characteristics independently 
associated with the child being fully vaccinated.
Results—The percentages of children aged 6 months-8 years who were fully vaccinated during 
the 2012-2013 and 2013-2014 influenza seasons were 41.0% and 45.2%, respectively. Full 
vaccination varied widely by state and was more likely for children requiring only one dose. Based 
on the statistical models, children likely to be fully vaccinated were older, non-black, had a mother 
with an education > 12 years, or lived in a high-income household.
Conclusions—Most children in the U.S. are not fully vaccinated against influenza. Reminder 
systems and interventions that reduce or remove barriers to children receiving their second doses 
of influenza vaccine may improve full influenza vaccination coverage among all children.
Introduction
Influenza infections are associated with significant morbidity and mortality in children.1 
Furthermore, children have been found to play a large role in transmission of influenza into 
their household.2 Household contacts of influenza-positive children have been found to have 
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more missing work or school days and more medical visits.3 Influenza vaccination is the 
most effective strategy to prevent people from getting influenza and influenza-related 
complications.4
The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza 
vaccination for all people aged ≥6 months.4 Two doses, administered a minimum of 4 weeks 
apart, is recommended for many children aged 6 months–8 years to ensure they obtain the 
optimum immune response and protection from influenza disease.5,6 The ACIP definition of 
which children aged < 9 years require two doses to be considered fully vaccinated has varied 
from season to season.7–17 Two approaches were recommended by ACIP for the 2012-2013 
and 2013-2014 influenza seasons. 15,16 According to the first approach, during the 
2012-2013 and 2013-2014 seasons, children aged 6 months-8 years needed only one dose if 
they had received a total of two or more doses of seasonal vaccine since July 1, 2010, 
whereas children who had not received two or more doses of seasonal vaccine since July 1, 
2010, required two doses. The second approach involves taking into account a child's 
vaccination history prior to July 1, 2010, when it is available.
Although parent-reported influenza vaccination coverage with one or more dose has been 
routinely reported for children aged 6 months–17 years since the 2010–2011 season using 
the National Immunization Survey Flu (NIS-Flu) and during the 2009–2010 season using the 
National H1N1 Flu Survey, national estimates of full vaccination coverage among all 
children aged 6 months–8 years have not been reported.18 Full vaccination coverage based 
upon provider-reported vaccinations among children aged 6–23 months has been published 
using data from NIS-Child.19 These estimates, however, cannot be produced for one 
influenza season before the start of the following influenza season owing to the time 
required to obtain provider data.19 Relying upon parental report of influenza vaccination 
status allows for timely production of estimates, as is done for the estimates of influenza 
vaccination coverage with one or more dose reported annually on FluVaxView.18 Some 
estimates of full influenza vaccination coverage based upon pediatric outpatient visits and on 
an HMO population have been reported.20,21 Likewise, estimates have been published based 
upon Immunization Information Systems (IIS) for select states and local areas that have 
well-developed registries, and at least one study has examined full influenza vaccination 
coverage using a hospital-based immunization registry.22–24 However, full vaccination 
coverage among children aged 6 months–8 years by state and sociodemographic 
characteristics has not yet been evaluated using a national sample. Identifying differences in 
full influenza vaccination coverage would be useful to immunization programs for targeting 
interventions and could help guide public health action to improve full influenza vaccination 
coverage. The objectives of this study were to quantify the percentage of children aged 6 
months–8 years who were fully vaccinated against influenza, based on parental report, 
overall, by state, and by sociodemographic characteristics and to examine sociodemographic 
characteristics associated with being fully vaccinated.
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Methods
Data Sample
Data from NIS-Flu for the 2012–2013 and 2013–2014 influenza seasons were analyzed in 
2015. NIS-Flu is a national list-assisted, random-digit-dialed, dual-frame (landline and 
cellular telephones) survey of households with children aged 6 months–17 years.25 NIS-Flu 
includes three components: NIS-Child for children aged 19–35 months, NIS-Teen for 
children aged 13–17 years, and the NIS-Child Influenza Module for children aged 6–18 
months and 3–12 years who are identified during screening households for NIS-Child and 
NIS-Teen.25–30 The Council of American Survey Research Organizations response rates for 
the 2012–2013 and 2013–2014 influenza seasons ranged from 52.2% to 63.4% for landline 
and 18.1% to 33.5% for cellular telephones.31 NIS-Flu included a total of 107,550 and 
130,409 children with completed interviews for the 2012–2013 and 2013–2014 seasons, 
respectively. This study restricted analyses to children aged 6 months–8 years (as of 
November 1 for each season, consistent with how age is defined for official Centers for 
Disease Control and Prevention estimates of one or more dose) and excluded children with 
missing vaccination status (3.7% in 2012–2013 and 2.7% in 2013–2014). The resulting 
sample sizes were 51,620 children for the 2012–2013 season and 65,848 children for the 
2013–2014 season.
Measures
Vaccination coverage estimates were based on interviews conducted October–June and 
included vaccinations received July–May of the respective influenza season. The main 
outcome measure was full vaccination. Estimates of coverage with one or more dose were 
also calculated.
Influenza vaccination status was assessed by asking the parent or guardian if the survey-
selected child in the household had received an influenza vaccination since July 1 and, if so, 
how many vaccinations and in which month and year the child received the first dose and in 
which month and year the child received the second dose if applicable. To assess history of 
vaccination, required to determine whether one or two doses were needed to be fully 
vaccinated, additional questions were asked. For the 2012–2013 season survey, the parent 
was asked, Did [selected child] receive any flu vaccinations during the last two flu seasons? 
This would be from July 1, 2010 to end of June 2012. If yes was selected, the following 
question was asked, How many flu vaccinations did [selected child] receive in the past two 
flu seasons, which were from July 1, 2010 to end of June 2012? Similar questions were 
asked for the 2013–2014 season. Note that for the 2013–2014 season the survey question 
was in reference to the last two influenza seasons (back to July 2011) and not the last three 
seasons (back to July 2010). Children for whom the number of doses needed to be fully 
vaccinated could not be determined owing to missing responses to the vaccination history 
questions (11.3% of vaccinated children in 2012–2013 and 9.7% of vaccinated children in 
2013–2014) were considered as needing two doses to be fully vaccinated. This approach 
reflects ACIP recommendations, which have a vaccination history response of don't know 
equated to no in the vaccination decision algorithm.17 The full vaccination estimates are 
based upon the Kaplan–Meier analyses with the event being time (in months) of receipt of 
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the dose that would make the child fully vaccinated (Dose 1 for those who needed only one 
dose and Dose 2 for those who needed two doses). For children reported to have been 
vaccinated but had a missing month and year of vaccination for their first (or only) dose 
(12.5% for the 2012–2013 season and 16.3% for the 2013–2014 season), month and year 
were imputed from donor pools matched for week of interview, age group, region of 
residence, and race/ethnicity using hot deck imputation. Likewise, for children reported to 
have received two doses of influenza vaccine but had a missing month and year of 
vaccination for their second dose (2.6% for the 2012–2013 season and 2.9% for the 2013–
2014 season), the month and year were imputed. For children reported to have not been fully 
vaccinated, they were censored on the month of interview. For all vaccination outcome 
measures, Kaplan–Meier survival analysis was used to obtain the cumulative vaccination 
coverage estimates as detailed in previous reports.32
Respondent-reported demographic characteristics included in this study were child's gender, 
age, and race/ethnicity; mother's education level; household poverty level; number of 
children aged <18 years in the household; and Metropolitan Statistical Area (MSA). The 
income/poverty level variable was defined based on total family income in the past calendar 
year, and the U.S. Census poverty thresholds for that year specified for the applicable family 
size and number of children aged <18 years.33
Statistical Analysis
Wald chi-square tests followed by post hoc pairwise comparison t-tests were used to test the 
associations between influenza vaccination status and demographic characteristics. 
Comparisons of influenza vaccination coverage estimates between the 2012–2013 and 
2013–2014 seasons were performed with t-tests assuming large df. Cox proportional hazards 
models were used to determine demographic characteristics independently associated with 
the child being fully vaccinated, and hazard ratios are reported. Proportional hazard 
assumptions were tested using time dependent covariates. All analyses were weighted to 
population totals and to adjust for households having multiple telephone lines, unit non-
response, and non-coverage of non-telephone households. All estimates, along with 95% 
CIs, were calculated using SAS, version 9.3, and SUDAAN, version 11.01, to account for 
the complex survey design. All tests were two-sided with a significance level of 0.05.
Results
Demographic characteristics of the study sample and the percentages requiring one versus 
two doses to be fully vaccinated are presented in Table 1. Overall, approximately two thirds 
of children required two doses to be fully vaccinated (2012–2013, 62.0%; 2013–2014, 
58.3%). These percentages were much higher for younger children, with 480% of children 
aged 6–23 months (2012–2013, 83.6%; 2013–2014, 81.2%) requiring two doses (Table 1).
The percentages of children aged 6 months–8 years who received one or more dose of 
influenza vaccination during the 2012–2013 and 2013–2014 influenza seasons were 65.9% 
and 67.2%, respectively, whereas the percentages of children fully vaccinated were 41.0% 
and 45.2%, respectively (Table 2). State variability in full vaccination coverage was large, 
Zhai et al. Page 4
Am J Prev Med. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
ranging from 28.0% in Oklahoma to 60.5% in Rhode Island during the 2012–2013 season 
and 31.1% in Idaho to 64.9% in Rhode Island during the 2013–2014 season (Table 3).
In bivariate analyses, full vaccination status varied by sociodemographic characteristics 
(Table 2). In both seasons, the percentage of fully vaccinated children aged 6–23 months 
was lower than those of children aged 2–4 years and 5–8 years. Hispanic, non-Hispanic 
white, and other/multiple race children had higher full vaccination coverage than non-
Hispanic black children. Children of mothers who were college graduates had higher full 
vaccination coverage than children of mothers with lower education levels. Children living 
in households above poverty with a household income 4$75,000 had the highest full 
vaccination coverage. Children in households with two children had higher full vaccination 
coverage than children in households with one or three or more children and children living 
in a non-MSA had lower full vaccination coverage than children living in an MSA. Among 
children who needed only one dose to be fully vaccinated, 90.6% in 2012–2013 and 93.2% 
in 2013–2014 received one or more doses and therefore were fully vaccinated. Among 
children who needed two doses to be fully vaccinated, the one or more dose coverage rate 
was 50.9% in 2012–2013 and 48.9% in 2013–2014, whereas the corresponding full 
vaccination coverage rates were 10.7% and 10.9%. Additional details of the associations 
with full coverage as well as associations with one or more dose coverage are shown in 
Table 2.
Results of the multivariable Cox proportional hazard models are shown in Table 4 and were 
similar to results from the bivariate analyses. Generally, the models showed that the children 
most likely to be fully vaccinated were those who were aged 46–23 months, non-black, had 
a mother with an education 412 years, or lived in a high-income household (Table 4).
Discussion
The results of this study indicate that only approximately two of every five children aged 6 
months–8 years in the U.S. were fully vaccinated against influenza in the two studied 
influenza seasons. Approximately 60% of these children required two doses of influenza 
vaccine to be considered fully vaccinated against influenza. Among those children who 
required two doses, about half received at least one dose in 2012–2013 and 2013– 2014, but 
only about 10% were fully vaccinated with two doses. The finding that approximately half 
of children who required two doses of influenza vaccine received their first but not second 
dose suggests there are barriers to receipt of the second required dose. These findings are 
similar to what was found based upon a study using provider-reported vaccination 
information, finding that for the subset of children aged 6–23 months requiring two doses 
and who received one dose, only 64% went on to receive their required second dose.19 A 
study based on IIS data reported estimates of full influenza vaccination coverage stratified 
by age for the 2012–2013 and 2013–2014 seasons; these estimates were 46.8% and 47.0% 
for children aged 6–23 months, 38.9% and 38.8% for children aged 2–4 years, and 30.9% 
and 32.7% for children aged 5–8 years, respectively.34 These IIS estimates are higher than 
the estimates from this study for children aged 6–23 months but lower for children aged 2–4 
years and 5–8 years. Additionally, this IIS study found that for the subset of children aged 
6–23 months requiring two doses and who received one dose, 65.6% (in 2012–2013) and 
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67.6% (in 2013–2014) went on to receive their required second dose.34 Barriers to receipt of 
the second dose might include inconvenience, difficulty making a doctor appointment, 
insurance/financial barriers, difficulty getting time off of work, lack of provider–parent 
discussions on the importance of returning for the child's second dose, parental beliefs and 
attitudes about vaccine effectiveness and safety, or other unknown factors.35
Children aged 6–23 months had lower full influenza vaccination coverage than older 
children. Preventing influenza among infants and young children is a public health priority 
because of their high risk for influenza-related complications.36,37 The second dose is 
essential, as evidenced by at least one study, which found that receipt of two doses of 
influenza vaccine was 69% effective against office visits for influenza-like illness and 87% 
effective against office visits for influenza-related pneumonia, whereas receipt of one dose 
did not prevent office visits at all for children aged 6–21 months.6 More widespread use of 
strategies known to increase second dose vaccination rates is warranted.38 One study found 
that text reminders that educated the parent on the importance of the second dose were 
effective at increasing the percentage of children who received their needed second dose.39
This study found racial/ethnic differences in full vaccination coverage that were in contrast 
to one or more dose coverage. Non-Hispanic black children had lower full vaccination 
coverage compared to all of the other race/ethnicity groups in both the 2012–2013 and 
2013–2014 seasons; however, black and white children had similar one or more dose 
coverage. This suggests there may be more barriers for black children to receive their second 
dose. Another recent study of full vaccination coverage of children aged 6–23 months based 
upon provider report likewise found that black children had lower full vaccination coverage 
than white children for all ten studied influenza seasons.19 Minority children have also been 
found to have a longer interval between first and second doses.24
Children of mothers with a college degree and children living in households with a higher 
annual household income consistently had higher full vaccination coverage. Studies of other 
childhood vaccinations had likewise shown that lower family income was associated with 
lower vaccination rates, perhaps because of numerous barriers faced by lower-income 
families such as lack of access to medical care, transportation issues, difficulty obtaining 
time off of work, and other barriers.40,41 Children living in an MSA had higher full 
vaccination coverage than children residing in non-MSAs, suggesting there might be 
additional barriers to children in non-MSAs receiving their second required dose. As seen in 
publications on one or more dose influenza vaccination coverage among children, large 
variability in full influenza vaccination coverage by state was also found.42,43 It is unknown 
why this variability exists, but factors likely include differences in programmatic and 
provider implementation of influenza recommendations, medical care delivery 
infrastructure, population norms, state and local immunization program efforts and 
resources, and other factors.44,45 Further study is needed to understand the variability in full 
influenza vaccination coverage between states.
Limitations
This study is subject to the following limitations. First, NIS-Flu is a telephone survey and 
selection and non-response bias is possible and may remain after weighting adjustments. 
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Second, the Council of American Survey Research Organizations response rate was low, 
especially for the cellular sample, and non-response bias may remain even after weighting 
adjustments. Third, influenza vaccination status was based on parental report and was not 
validated with medical records. Validity studies have shown that parents may overreport 
their child's influenza vaccination status and this may vary by race/ethnicity, income, and 
other sociodemographic charac-teristics.46 An analysis of full influenza vaccination based 
upon provider report among children aged 6–23 months found that full influenza vaccination 
coverage was 42.9% in the 2012–2013 season, higher than the 36.8% found in this paper 
based on parental report.19 Although parent report may not be equally valid as provider 
report, estimates based on parental report can be obtained for one influenza season before 
the start of the next, and have been routinely reported since 2009.18 Fourth, the 2013– 2014 
NIS-Flu questionnaire did not allow the precise measure of full influenza vaccination 
because the survey asked for vaccination history since July 1, 2011, rather than 2010. This 
likely led to an overestimation of the number of children who needed a second dose of 
influenza vaccine and resulted in an underestimation of full vaccination coverage rates for 
the 2013–2014 influenza season. Additionally, using only one ACIP approach and treating 
missing responses to vaccination history as needing two doses may have also resulted in 
underestimation of full vaccination coverage. Fifth, when evaluating the proportional 
hazards assumption for the Cox model, age group did not satisfy the assumption but was 
kept in the final Cox regression because it was a primary variable of interest. The literature 
suggests that the proportional hazards model is robust to departures from this assumption.
47–49
Conclusions
This study indicates that the percentage of children aged 6 months–8 years who are fully 
vaccinated against influenza remains low. These results demonstrate the need for continued 
emphasis of the importance of younger children receiving their second influenza dose when 
it is needed. Targeted interventions based on sociodemographic factors associated with low 
coverage, interventions recommended by the Community Guide such as expanded access in 
healthcare settings, intensive outreach and home visits, client reminder and recall systems, 
and client or community-wide education can help improve coverage.38
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Table 1
Demographic Characteristics of the Study Population of Children 6 Months Through 8 
Years
Demographic characteristic
2012–2013 influenza season 2013–2014 influenza season
Unweighted n Weighted % (±95% CI) Unweighted n Weighted % (±95% CI)
Overall 51,620 100 65,848 100
Gender
 Male 26,593 51.0 (0.9) 33,789 51.3 (0.9)
 Female 25,027 49.0 (0.9) 32,059 48.7 (0.9)
Agea
 6–23 months 10,632 17.1 (0.7) 13,414 17.4 (0.6)
 2–4 years 18,082 33.6 (0.9) 22,782 33.5 (0.8)
 5–8 years 22,906 49.4 (0.9) 29,652 49.1 (0.9)
Child's race/ethnicity
Hispanic 9,757 25.3 (1.0) 12,828 24.6 (0.9)
 Black, non-Hispanic 5,344 14.1 (0.7) 6,774 14.1 (0.7)
 White, non-Hispanic 30,250 50.7 (1.0) 37,970 51.4 (0.9)
 Other/multiple races, non-Hispanic 6,269 10.0 (0.6) 8,276 9.8 (0.5)
Mother's education level
 <12 years 4,938 12.7 (0.7) 6,499 13.1 (0.7)
 12 years 9,704 20.5 (0.8) 12,039 19.3 (0.7)
 >12 years, not college graduate 13,077 25.6 (0.9) 16,663 25.5 (0.8)
 College graduate 21,940 38.0 (0.9) 28,070 38.6 (0.8)
Poverty statusb
 Above poverty, >$75,000/year 18,278 30.1 (0.9) 23,596 30.8 (0.8)
 Above poverty, ≤$75,000/year 18,845 35.2 (0.9) 23,122 33.3 (0.8)
 At or below poverty level 9,711 25.9 (1.0) 12,520 25.3 (0.9)
 Unknown 4,786 8.9 (0.5) 6,610 10.5 (0.5)
No. of children o18 in household
 1 child 17,578 25.8 (0.8) 21,005 23.5 (0.7)
 2 children 20,653 41.4 (1.0) 26,301 40.9 (0.9)
 ≥3 children 13,206 32.7 (1.0) 18,276 35.4 (0.9)
Household in MSA
 MSA, principal city 18,067 34.8 (0.9) 18,331 27.5 (0.8)
 MSA, not principal city 22,318 48.9 (1.0) 34,460 58.1 (0.9)
 Non-MSA 11,235 16.3 (0.6) 13,057 14.4 (0.5)
Doses to be fully vaccinated
 1 dose 20,802 38.0 (0.9) 28,518 41.7 (0.9)
 2 doses 30,818 62.0 (1.0) 32,632 58.3 (0.9)
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Demographic characteristic
2012–2013 influenza season 2013–2014 influenza season
Unweighted n Weighted % (±95% CI) Unweighted n Weighted % (±95% CI)
6–23 months
 1 dose 2,128 16.4 (1.4) 2,974 18.8 (1.3)
 2 doses 8,504 83.6 (1.4) 10,440 81.2 (1.3)
2–4 years
 1 dose 7,989 41.1 (1.6) 10,678 45.4 (1.6)
 2 doses 10,093 58.9 (1.6) 12,104 54.6 (1.6)
5–8 years
 1 dose 10,685 43.3 (1.3) 14,866 47.3 (1.2)
 2 doses 12,221 56.7 (1.3) 14,786 52.7 (1.2)
Source: National Immunization Survey-Flu (NIS-Flu), 2012–2013 and 2013–2014 influenza seasons.
aAge as of November 1 of the respective influenza season.
b
Income/poverty level was defined based on total family income in the past calendar year, and the U.S. Census poverty thresholds for that year 
specified for the applicable family size and number of children aged <18 years. Poverty thresholds are available at www.census.gov/hhes/www/
poverty/data/threshld/index.html.
MSA, Metropolitan Statistical Area; No., number.
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Table 2
Influenza Vaccination Coverage Among Children 6 Months Through 8 Years, by 
Characteristics and Dose Recommendations
Demographic characteristic
2012–2013 influenza season, estimate a (±95% 
CI)
2013–2014 influenza season, estimate (±95% 
CI)
≥1 dose b Fully vaccinated c ≥1 dose Fully vaccinated
Overall 65.9 (1.2) 41.0 (1.1) 67.2 (1.1) 45.2 (1.3)f
Gender
 A. Male 66.1 (1.6) 41.7 (1.6) 66.9 (1.4) 45.1 (1.7)f
 B. Female 65.6 (1.7) 40.4 (1.6) 67.5 (1.7) 45.3 (1.8)f
Aged
 A. 6–23 months 77.0 (2.3)g,B,C 36.8 (2.3)B,C 74.4 (2.0)B,C 39.3 (2.3)B,C
 B. 2–4 years 65.9 (1.9)A,C 42.8 (2.1)A 68.1 (1.8)A,C 45.6 (2.3)A
 C. 5–8 years 61.7 (1.8)A,B 41.3 (1.6)A 63.9 (1.7)A,B 47.0 (1.8)f,A
Child's race/ethnicity
 A. Hispanic 69.0 (2.8)B,C 41.4 (2.8)B 74.2 (2.9)f,B,C 47.9 (3.9)f,B
 B. Black, non-Hispanic 63.5 (3.6)A,D 33.9 (3.0)A,C,D 63.3 (3.0)A,D 37.8 (3.2)A,C,D
 C. White, non-Hispanic 64.0 (1.4)A,D 42.5 (1.4)B 64.2 (1.2)A,D 45.9 (1.2)f,B
 D. Other/multiple races, non-
Hispanic
69.7 (3.7)B,C 42.5 (3.1)B 70.9 (2.7)B,C 46.3 (2.9)B
Mother's education level
 A. <12 years 66.7 (4.1)C 35.5 (3.6)D 72.5 (4.4)B,C 45.9 (5.4)f,B,C,D
 B. 12 years 63.5 (2.8)D 36.8 (2.6)D 64.0 (2.3)A,C,D 37.8 (3.2)A,D
C. >12 years, not college graduate 61.4 (2.3)A,D 37.8 (2.3)D 60.2 (2.1)A,B,D 39.5 (2.3)A,D
 D. College graduate 69.6 (1.7)B,C 47.9 (1.7)A,B,C 71.6 (1.3)B,C 53.2 (1.4)f,A,B,C
Poverty statuse
 A. Above poverty, >$75,000/year 71.2 (1.9)B,C,D 49.7 (1.9)B,C,D 71.2 (1.4)B 54.0 (1.6)f,B,C,D
 B. Above poverty, ≤$75,000/year 61.2 (2.0)A,C 38.1 (1.9)A 62.0 (1.7)A,B,D 40.0 (1.7)A,D
 C. At or below poverty level 67.0 (2.7)A,B 36.4 (2.5)A 68.6 (2.8)B 42.2 (1.9)f,A,D
 D. Unknown 63.7 (3.9)A 36.8 (3.6)A 68.9 (3.7)B 43.0 (4.1)f,A,B,C
No. of children <18 in household
 A. 1 child 67.9 (2.1)C 40.1 (2.1)B 67.6 (1.7) 41.3 (1.8)B
 B. 2 children 67.8 (1.8)C 44.1 (1.9)A,C 68.5 (1.5)C 48.2 (1.7)f,A,C
 C. ≥3 children 61.7 (2.3)A,B 37.8 (2.0)B 65.6 (2.2)f,B 42.2 (2.6)f,B
Household in MSA
 A. MSA, principal city 67.3 (2.0)C 40.4 (1.9)B,C 69.6 (2.0)C 45.2 (2.4)f,C
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Demographic characteristic
2012–2013 influenza season, estimate a (±95% 
CI)
2013–2014 influenza season, estimate (±95% 
CI)
≥1 dose b Fully vaccinated c ≥1 dose Fully vaccinated
 B. MSA, not principal city 66.7 (1.9)C 43.0 (1.8)A,C 67.8 (1.5)A,C 46.4 (1.7)f,C
 C. Non-MSA 60.1 (2.4)A,B 37.0 (2.2)A,B 60.2 (2.3)A,B 40.4 (2.3)f,A,B
No. of doses to be fully vaccinated
 A. 1 dose 90.6 (1.4)B 90.6 (1.4)B 93.2 (1.2)f,B 93.2 (1.2)f,B
 B. 2 dose 50.9 (1.6)A 10.7 (1.0)A 48.9 (1.3)A 10.9 (1.2)A
Source: National Immunization Survey-Flu (NIS-Flu), 2012–2013 and 2013–2014 influenza seasons.
a
Influenza vaccination coverage estimates were calculated using the Kaplan–Meier survival analysis procedure. For the 2012–2013 season, 
estimates include vaccinations received from July 2012 through May 2013 and are based on interviews conducted October 2012 through June 2013. 
For the 2013–2014 season, estimates include vaccinations received from July 2013 through May 2014 and are based on interviews conducted 
October 2013 through June 2014.
bAny (≥1) dose defined as receipt of at least one dose of influenza vaccine.
c
Fully vaccinated was defined as either (1) receipt of two doses of influenza vaccine for children who were previously unvaccinated or did not 
receive a total of two or more doses of influenza vaccine from July 1, 2010, to the end of June 2012 for the 2012–2013 influenza seasons or June 
2013 for the 2013–2014 influenza season, or (2) receipt of one dose of influenza vaccine otherwise.
dAge as of November 1 of the respective influenza season.
e
Income/poverty level was defined based on total family income in the past calendar year, and the U.S. Census Poverty thresholds for that year 
specified for the applicable family size and number of children aged <18 years. Poverty thresholds are available at http://www.census.gov/
hhes/www/poverty/data/threshld/index.html.
fStatistically significant difference compared to the 2012–2013 influenza season estimate.
g
The presence or absence of capital letters denotes whether that estimate was statically significantly different at p<0.05 from another row, and 
denotes which row it differed from (A, B, C, D), based on pairwise comparison t-test. For example, the 77.0% of ≥1 dose vaccination coverage 
estimate of 6–23 months (A) was statistically significantly different from the 65.9% of coverage estimates of 2–4 years (B) and 61.7% of 5–8 years 
(C) in the 2012–2013 season.
MSA, Metropolitan Statistical Area; No., number.
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Table 4
Demographic Characteristics Associated With Full Influenza Vaccination Coverage 
Among Children 6 Months Through 8 Years
Demographic characteristics
Fully vaccinated, a HR (95% CI)
2012–2013 influenza season 2013–2014 influenza season
Gender
 Male 1.04 (0.98, 1.11) 0.99 (0.93, 1.05)
 Female ref ref
Ageb
 6–23 months ref ref
 2–4 years 1.50 (1.37, 1.64) 1.52 (1.40, 1.65)
 5–8 years 1.41 (1.30, 1.54) 1.49 (1.38, 1.60)
Child's race/ethnicity
 Hispanic 1.27 (1.11, 1.44) 1.35 (1.20, 1.53)
 Black, non-Hispanic ref ref
 White, non-Hispanic 1.22 (1.09, 1.36) 1.21 (1.10, 1.35)
 Other/multiple races, non-Hispanic 1.21 (1.05, 1.40) 1.25 (1.11, 1.42)
Mother's education level
 <12 years ref ref
 12 years 1.11 (0.96, 1.28) 0.88 (0.77, 1.00)
>12 years, not college graduate 1.16 (1.00, 1.34) 0.98 (0.85, 1.13)
College graduate 1.44 (1.25, 1.65) 1.34 (1.18, 1.52)
Poverty statusc
 Above poverty, >$75,000/year 1.28 (1.18, 1.39) 1.31 (1.22, 1.41)
 Above poverty, ≤$75,000/year ref ref
 At or below poverty level 1.02 (0.91, 1.14) 1.05 (0.94, 1.17)
 Unknown 0.91 (0.80, 1.04) 0.99 (0.88, 1.11)
No. of children <18 in household
 1 child 1.01 (0.92, 1.10) 0.99 (0.92, 1.07)
 2 children 1.13 (1.04, 1.22) 1.12 (1.04, 1.20)
 ≥3 children ref ref
Household in MSA
 MSA, principal city 1.08 (0.98, 1.18) 1.07 (0.97, 1.17)
 MSA, not principal city 1.16 (1.06, 1.26) 1.06 (0.98, 1.15)
 Non-MSA ref ref
Source: National Immunization Survey-Flu (NIS-Flu), 2012–2013 and 2013–2014 influenza seasons.
Note: Boldface indicates statistical significance (p<0.05) compared to the referent group.
a
Fully vaccinated was defined as either (1) receipt of two doses of influenza vaccine for children who were previously unvaccinated or did not 
receive a total of two or more doses of influenza vaccine from July 1, 2010, to the end of June 2012 for the 2012–2013 influenza seasons or June 
2013 for the 2013–2014 influenza season, or (2) receipt of one dose of influenza vaccine otherwise.
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bAge as of November 1 of the respective influenza season.
c
Income/poverty level was defined based on total family income in the past calendar year, and the U.S. Census poverty thresholds for that year 
specified for the applicable family size and number of children <18 years. Poverty thresholds are available at www.census.gov/hhes/www/poverty/
data/threshld/index.html.
HR, hazard ratio; MSA, Metropolitan Statistical Area; No., number.
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